Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Sales | 0 | 0 | 0 | 6,050 | 200 |
| Gross Profit | N/A | N/A | N/A | 0 | 200 |
| Operating Expenses | 3,300 | 3,578 | 2,717 | 2,700 | 2,520 |
| Operating Income | -3,300 | -3,578 | -2,717 | 3,350 | -2,320 |
| Interest Expense | 0 | 0 | 345 | 230 | 210 |
| Other Income | 380 | 249 | 111 | -9,310 | -1,540 |
| Pre-tax Income | -2,920 | -3,328 | -2,951 | -6,190 | -4,070 |
| Net Income Continuous | -2,920 | -3,328 | -2,951 | -7,299 | -4,077 |
| Net Income | $-2,920 | $-3,328 | $-2,951 | $-7,299 | $-4,077 |
| EPS Basic Total Ops | -3,500.00 | -4,250.00 | -4,250.00 | -11,750.00 | -6,750.00 |
| EPS Basic Continuous Ops | -3,540.88 | -4,277.89 | -4,325.93 | -11,750.00 | -6,750.00 |
| EPS Diluted Total Ops | -3,500.00 | -4,250.00 | -4,250.00 | -2.35 | -1.35 |
| EPS Diluted Continuous Ops | -3,540.88 | -4,277.89 | -4,325.93 | -12,165.00 | -6,795.00 |
| EBITDA(a) | $-3,296 | $-3,575 | $-2,702 | $3,380 | $-2,320 |